Literature DB >> 20587274

Strategy for Prevention of Restenosis after PTA. Clinical and Basic Approaches.

S Yoshimura1, Y Kaku, J Kokuzawa, K Hayashi, N Sakai.   

Abstract

SUMMARY: Percutaneous transluminal angioplasty (PTA) has been a useful therapy to treat stenosis of cervical internal carotid artery (ICA) or vertebral artery (VA). Here we show that our clinical results regarding preventive effect of stenting on restenosis after PTA in the ICA and VA origin. We also show our experimental studies with gene transfer techniques aiming reduction of restenosis after balloon-injury in rat carotid artery. It has been reported that drug-eluting stent inhibits restenosis after coronary angioplasty. Further understanding of the mechanism of restenosis and application of these new modalities may lead to better clinical results in angioplasty of the craniocervical arteries.

Entities:  

Year:  2008        PMID： 20587274      PMCID： PMC3490176          DOI： 10.1177/15910199040100S108

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN： 1591-0199            Impact factor:   1.610


  13 in total

1.  Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

Authors:  D B Landry; L L Couper; S R Bryant; V Lindner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Vertebral artery stenting following percutaneous transluminal angioplasty. Technical note.

Authors:  G S Storey; M P Marks; M Dake; A M Norbash; G K Steinberg
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

3.  Global experience in cervical carotid artery stent placement.

Authors:  M H Wholey; M Wholey; K Mathias; G S Roubin; E B Diethrich; M Henry; S Bailey; P Bergeron; G Dorros; G Eles; P Gaines; C R Gomez; B Gray; J Guimaraens; R Higashida; D S Ho; B Katzen; A Kambara; V Kumar; J C Laborde; M Leon; M Lim; H Londero; J Mesa; A Musacchio; S Myla; S Ramee; A Rodriquez; K Rosenfield; N Sakai; F Shawl; H Sievert; G Teitelbaum; J G Theron; P Vaclav; C Vozzi; J S Yadav; S I Yoshimura
Journal:  Catheter Cardiovasc Interv       Date:  2000-06       Impact factor: 2.692

4.  Elective stenting of the extracranial carotid arteries.

Authors:  J S Yadav; G S Roubin; S Iyer; J Vitek; P King; W D Jordan; W S Fisher
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

5.  Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.

Authors:  J E Sousa; M A Costa; A C Abizaid; B J Rensing; A S Abizaid; L F Tanajura; K Kozuma; G Van Langenhove; A G Sousa; R Falotico; J Jaeger; J J Popma; P W Serruys
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

6.  Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.

Authors:  S Yoshimura; R Morishita; K Hayashi; K Yamamoto; H Nakagami; Y Kaneda; N Sakai; T Ogihara
Journal:  Gene Ther       Date:  2001-11       Impact factor: 5.250

7.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Authors:  R Morishita; G H Gibbons; K E Ellison; M Nakajima; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

9.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

10.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.

Authors:  K Brand; S Page; G Rogler; A Bartsch; R Brandl; R Knuechel; M Page; C Kaltschmidt; P A Baeuerle; D Neumeier
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808
View more
  1 in total

1.  Early growth response protein 1 promotes restenosis by upregulating intercellular adhesion molecule-1 in vein graft.

Authors:  Kui Zhang; Jian Cao; Ran Dong; Jie Du
Journal:  Oxid Med Cell Longev       Date:  2013-12-09       Impact factor: 6.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.